Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 10;16(1):211.
doi: 10.1186/s12944-017-0602-7.

Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia)

Affiliations

Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia)

Mahwish et al. Lipids Health Dis. .

Abstract

Background: Cardiovascular diseases and diabetes are responsible for large number of deaths throughout the globe. Bitter gourd has the potential to become a component of the diet or a dietary supplement for diabetic and pre-diabetic patients owing to the presence of insulin like molecules. Recent investigations have suggested that bitter gourd extracts may ameliorate high fat diet induced obesity and hyperlipidemia in animal models. Moreover, its supplements in food result in lowering weight gain and visceral fat mass.

Methods: The current study was designed to investigate the nutraceutical potential of skin, flesh and whole fruit of bitter gourd cultivars against hyperglycemia and hyperlipidemia. For the purpose, various bitter gourd cultivars were procured from local market. Bio-evaluation studies were carried out on biochemical parameters using rodent experiment model.

Results: From results, it was revealed that maximum reduction in blood glucose skin 1.06%, flesh 2.65%, whole fruit 4.29%, total cholesterol skin 6.60%, flesh 6.04%, whole fruit 6.70%, low density lipoprotein skin 5.55%, flesh 6.81%, whole fruit 6.60%, and triglycerides skin 0.04%, flesh 3.38%, whole fruit 2.02%, were observed. Moreover, insulin skin 2.14%, flesh 3.52%, whole fruit 2.73%, production was slightly enhanced with improved levels of high density lipoprotein in whole fruit of bitter gourd.

Conclusion: Overwhelmingly, it may be inferred here that bitter gourd holds the potential to significantly improve diabetic conditions and associated late complications with no ill effects on body organs.

Keywords: Bitter gourd; Functional foods; Hyperglycemia; Hyperlipidemia; Nutraceutical.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not Applicable

Consent for publication

Not Applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Feed intake (g/rat/day) in different studies with different diets
Fig. 2
Fig. 2
Water intake (mL/rat/day) in different studies with different diets
Fig. 3
Fig. 3
Body weight gain (g/rat/day) in different studies with different diets

Similar articles

Cited by

References

    1. Mugisha JO, Schatz EJ, Randell M, Kuteesa M, Kowal P, Negin J, Seeley J. Chronic disease risk factors and disability in adults aged 50 and above living with and without HIV: findings from the wellbeing of older people study in Uganda. Glob Health Action. 2016;9:31098. doi: 10.3402/gha.v9.31098. - DOI - PMC - PubMed
    1. Dayoub E, Jena AB. Chronic disease prevalence and healthy lifestyle behaviors among US health care professionals. Mayo Clin Proc. 2015;90(12):1659. doi: 10.1016/j.mayocp.2015.08.002. - DOI - PMC - PubMed
    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Prac. 2010;87(1):4. doi: 10.1016/j.diabres.2009.10.007. - DOI - PubMed
    1. Abid R, Mahmood R, Kumar HSS. Hypolipidemic and antioxidant effects of ethanol extract of Cassia Fistula fruit in hyperlipidemic mice. Pharm Biol. 2016;1:8. - PubMed
    1. Mundal L, Retterstl K. A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries. Curr Opin Lipidol. 2016;27(4):388–397. doi: 10.1097/MOL.0000000000000300. - DOI - PubMed